Biosimilar monoclonal antibodies in China: A patent review
Sign Up to like & getrecommendations! Published in 2022 at "Bioengineered"
DOI: 10.1080/21655979.2022.2090206
Abstract: ABSTRACT Biosimilars play an important role in reducing the burden on patients and increasing the market competition. Biosimilar monoclonal antibodies are currently one of the hotspots of research and development in China with policies support.… read more here.
Keywords: antibodies china; patent review; china patent; biosimilar monoclonal ... See more keywords
Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
Sign Up to like & getrecommendations! Published in 2019 at "Antibodies"
DOI: 10.3390/antib8010021
Abstract: The development of hybridoma technology for producing monoclonal antibodies (mAbs) by Kohler and Milstein (1975) counts as one of the major medical breakthroughs, opening up endless possibilities for research, diagnosis and for treatment of a… read more here.
Keywords: innovative biosimilar; immunogenicity; antibodies immunogenicity; monoclonal antibodies ... See more keywords
Stability Evaluation of the Biosimilar Monoclonal Antibody Using Analytical Techniques.
Sign Up to like & getrecommendations! Published in 2022 at "Turkish journal of pharmaceutical sciences"
DOI: 10.4274/tjps.galenos.2022.47690
Abstract: Objectives Determination of the drug substance (DS) and drug product (DP) stability is especially important for biosimilar monoclonal antibodies since it can affect the quality, efficacy, and safety of the drugs. The main objective of… read more here.
Keywords: analytical techniques; stability evaluation; monoclonal antibody; biosimilar monoclonal ... See more keywords